Prestige Consumer Healthcare Inc. (PBH)

NYSE: PBH · IEX Real-Time Price · USD
68.48
-0.92 (-1.33%)
Jun 24, 2024, 4:00 PM EDT - Market closed
-1.33%
Market Cap 3.42B
Revenue (ttm) 1.13B
Net Income (ttm) 209.34M
Shares Out 49.92M
EPS (ttm) 4.17
PE Ratio 16.68
Forward PE 15.65
Dividend n/a
Ex-Dividend Date n/a
Volume 340,047
Open 69.47
Previous Close 69.40
Day's Range 68.48 - 71.42
52-Week Range 56.34 - 75.31
Beta 0.50
Analysts Strong Buy
Price Target 86.50 (+26.31%)
Earnings Date Aug 1, 2024

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain... [Read more]

Sector Healthcare
IPO Date Feb 10, 2005
Employees 560
Stock Exchange NYSE
Ticker Symbol PBH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for PBH stock is "Strong Buy." The 12-month stock price forecast is $86.5, which is an increase of 26.31% from the latest price.

Price Target
$86.5
(26.31% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on M...

18 days ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results

TARRYTOWN, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2024.

5 weeks ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on Tues...

2 months ago - GlobeNewsWire

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art ...

2 months ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

TARRYTOWN, N.Y., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2023.

4 months ago - GlobeNewsWire

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete's ...

5 months ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday, February ...

5 months ago - GlobeNewsWire

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine Topi...

6 months ago - GlobeNewsWire

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate At...

7 months ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

TARRYTOWN, N.Y., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2023.

8 months ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday, November...

9 months ago - GlobeNewsWire

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, Septemb...

10 months ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results

TARRYTOWN, N.Y., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter ended June 30, 2023.

11 months ago - GlobeNewsWire

Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results

TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first quarter earnings release on Thursday, August 3,...

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Publishes Inaugural Sustainability Report

TARRYTOWN, N.Y., July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced the release of its inaugural Environmental, Social, and C...

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare to Present at Upcoming Investor Conferences

TARRYTOWN, N.Y., June 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the William Blair Growth Stock Conference in Chicago on Tuesday, June...

1 year ago - GlobeNewsWire

Goody's® Introduces New “GET TO GOOD™” Marketing Campaign

The Powdered Pain Relief Brand Highlights Typical Consumers Who Cannot Let Discomfort Slow Them Down The Powdered Pain Relief Brand Highlights Typical Consumers Who Cannot Let Discomfort Slow Them Dow...

1 year ago - GlobeNewsWire

Dramamine® Eases Americans' Travel Woes with ‘Ditch the Drama' Sweepstakes Offering a Vacation to Anywhere in the World

This comes as 72% of Americans say they prefer someone else handle the planning for them, and nearly a third of Americans saying their plans won't be finalized until weeks before. This comes as 72% of...

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023

TARRYTOWN, N.Y., May 04, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2023.

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Third Quarter Results

TARRYTOWN, N.Y., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third fiscal quarter ended December 31, 2022.

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results

TARRYTOWN, N.Y., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 third quarter earnings release on Thursday, February ...

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023

TARRYTOWN, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second fiscal quarter ended September 30, 2022.

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November...

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference

TARRYTOWN, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) will present at the 2022 Barclays Global Consumer Staples Conference on Thursday, September 8, 2022 at ...

1 year ago - GlobeNewsWire

Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023

TARRYTOWN, N.Y., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first fiscal quarter ended June 30, 2022.

2 years ago - GlobeNewsWire